9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Cancer antigen 125 as a biomarker in peritoneal dialysis: mesothelial cell health or death?

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The concentration or appearance rate of cancer antigen 125 (CA125) in peritoneal dialysis (PD) effluent has been used for many years as a biomarker for mesothelial cell mass in patients on PD. However, this marker has limitations, and emerging evidence has raised doubts as to its significance. This review explores our current understanding of CA125, its prominent role in studies of "biocompatible" PD solutions, and the ongoing uncertainty concerning its interpretation as a measure of mesothelial cell health.

          Related collections

          Author and article information

          Journal
          Perit Dial Int
          Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis
          MultiMed Inc.
          1718-4304
          0896-8608
          July 12 2013
          : 33
          : 4
          Affiliations
          [1 ] Division of Nephrology, University Health Network, and Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
          Article
          33/4/349
          10.3747/pdi.2012.00320
          3707709
          23843586
          524c9d21-03c4-4c0e-b03b-e6075682b79d
          History

          CA125,Cancer antigen 125,biocompatibility,biomarkers,mesothelial cell mass,peritonitis

          Comments

          Comment on this article